| Symbol | Sector | Firm | Action | Grade | Target | Mkt Cap ▼ | Base | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCA | Healthcare | Raymond James | Downgrade | Outperform → Market Perform | — | $93.4B | $332.24 | -1.1% | -2.2% | +0.2% | +1.0% | -1.1% | +0.5% |
| RBLX | Technology | Raymond James | Maintains | Strong Buy → Strong Buy | — | $30.7B | $49.35 | -0.1% | +0.1% | -0.4% | -0.2% | +0.6% | +1.5% |
| THC | Healthcare | Raymond James | Downgrade | Strong Buy → Outperform | — | $17.4B | $147.92 | -1.8% | -2.9% | -0.2% | +1.6% | -2.5% | +0.5% |
| WAY | Technology | Raymond JamesA | Upgrade | Outperform → Strong Buy | — | $3.9B | $31.14 | +2.0% | +0.4% | -0.9% | -0.3% | -0.9% | +0.9% |
| CYH | Healthcare | Raymond James | Downgrade | Market Perform → Underperform | — | $378M | $3.75 | -3.5% | -2.7% | +1.4% | -3.5% | -3.1% | -0.6% |